Characterization of the novel HLA-A*26:208 allele by sequencing-based typing.

Alleles HLA Antigens HLA-A Antigens / genetics High-Throughput Nucleotide Sequencing Histocompatibility Testing Humans Sequence Analysis, DNA
HLA-A*26:208 NGS human leucocyte antigen novel HLA allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
06 2021
Historique:
received: 01 03 2021
accepted: 03 03 2021
pubmed: 13 3 2021
medline: 8 7 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

The novel HLA-A*26:208 allele was characterized using two next generation sequencing technologies.

Identifiants

DOI: 10.1111/tan.14254 PMID: 33709621
pubmed: 33709621
doi: 10.1111/tan.14254
doi:

Substances chimiques

HLA Antigens 0
HLA-A Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

534-535

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Ma C, Flicek P, SGE M. IPD-IGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Celine Dard (C)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-5843-0842

Alexandre Walencik (A)

Histocompatibility laboratory, Etablissement Français du Sang Centre-Pays de la Loire, Nantes, France.
ORCID: 0000-0001-7748-2982

Imad Oukasse (I)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-7226-6719

Béatrice Bardy (B)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-8426-0007

Dominique Masson (D)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-6995-4713

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel HLA-A*26:208...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Characterization of the novel HLA-A*26:208...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-A › Characterization of the novel HLA-A*26:208...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Characterization of the novel HLA-A*26:208...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Characterization of the novel HLA-A*26:208...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization of the novel HLA-A*26:208...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Characterization of the novel HLA-A*26:208...